The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pemetrexed Drug Market Research Report 2025
Synopsis
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
The global Pemetrexed Drug market was valued at US$ 86 million in 2023 and is anticipated to reach US$ 117.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Pemetrexed is a chemotherapy drug primarily used for the treatment of certain types of lung cancer and mesothelioma. The global market for Pemetrexed is driven by several factors, including the rising incidence of lung cancer and mesothelioma worldwide. These cancers continue to be major public health concerns, and the demand for effective treatments like Pemetrexed remains high. Additionally, advancements in medical research and technology have led to the development of novel chemotherapy drugs, including Pemetrexed, which have shown promising results in clinical trials. This has further contributed to the demand for Pemetrexed in the global market. Moreover, the increasing healthcare infrastructure and expenditure in emerging economies like China, India, and Brazil have opened up new growth opportunities for Pemetrexed manufacturers. These countries have witnessed a significant rise in the number of cancer cases and are investing in improved healthcare facilities, which is expected to boost the market for Pemetrexed.
This report aims to provide a comprehensive presentation of the global market for Pemetrexed Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Drug.
Report Scope
The Pemetrexed Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pemetrexed Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Segment by Type
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
Segment by Application
Pleural mesothelioma
Non-small cell lung cancer
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
The global Pemetrexed Drug market was valued at US$ 86 million in 2023 and is anticipated to reach US$ 117.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Pemetrexed is a chemotherapy drug primarily used for the treatment of certain types of lung cancer and mesothelioma. The global market for Pemetrexed is driven by several factors, including the rising incidence of lung cancer and mesothelioma worldwide. These cancers continue to be major public health concerns, and the demand for effective treatments like Pemetrexed remains high. Additionally, advancements in medical research and technology have led to the development of novel chemotherapy drugs, including Pemetrexed, which have shown promising results in clinical trials. This has further contributed to the demand for Pemetrexed in the global market. Moreover, the increasing healthcare infrastructure and expenditure in emerging economies like China, India, and Brazil have opened up new growth opportunities for Pemetrexed manufacturers. These countries have witnessed a significant rise in the number of cancer cases and are investing in improved healthcare facilities, which is expected to boost the market for Pemetrexed.
This report aims to provide a comprehensive presentation of the global market for Pemetrexed Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Drug.
Report Scope
The Pemetrexed Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pemetrexed Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Segment by Type
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
Segment by Application
Pleural mesothelioma
Non-small cell lung cancer
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pemetrexed Drug Market Overview
1.1 Product Overview and Scope of Pemetrexed Drug
1.2 Pemetrexed Drug Segment by Type
1.2.1 Global Pemetrexed Drug Market Value Comparison by Type (2024-2030)
1.2.2 100 mg lyophilized powder/vial
1.2.3 500 mg lyophilized powder/vial
1.3 Pemetrexed Drug Segment by Application
1.3.1 Global Pemetrexed Drug Market Value by Application: (2024-2030)
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Global Pemetrexed Drug Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Drug Revenue 2019-2030
1.4.2 Global Pemetrexed Drug Sales 2019-2030
1.4.3 Global Pemetrexed Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pemetrexed Drug Market Competition by Manufacturers
2.1 Global Pemetrexed Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pemetrexed Drug Average Price by Manufacturers (2019-2024)
2.4 Global Pemetrexed Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pemetrexed Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pemetrexed Drug, Product Type & Application
2.7 Pemetrexed Drug Market Competitive Situation and Trends
2.7.1 Pemetrexed Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pemetrexed Drug Players Market Share by Revenue
2.7.3 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pemetrexed Drug Retrospective Market Scenario by Region
3.1 Global Pemetrexed Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pemetrexed Drug Global Pemetrexed Drug Sales by Region: 2019-2030
3.2.1 Global Pemetrexed Drug Sales by Region: 2019-2024
3.2.2 Global Pemetrexed Drug Sales by Region: 2025-2030
3.3 Global Pemetrexed Drug Global Pemetrexed Drug Revenue by Region: 2019-2030
3.3.1 Global Pemetrexed Drug Revenue by Region: 2019-2024
3.3.2 Global Pemetrexed Drug Revenue by Region: 2025-2030
3.4 North America Pemetrexed Drug Market Facts & Figures by Country
3.4.1 North America Pemetrexed Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pemetrexed Drug Sales by Country (2019-2030)
3.4.3 North America Pemetrexed Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pemetrexed Drug Market Facts & Figures by Country
3.5.1 Europe Pemetrexed Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pemetrexed Drug Sales by Country (2019-2030)
3.5.3 Europe Pemetrexed Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pemetrexed Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Pemetrexed Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pemetrexed Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Pemetrexed Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pemetrexed Drug Market Facts & Figures by Country
3.7.1 Latin America Pemetrexed Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pemetrexed Drug Sales by Country (2019-2030)
3.7.3 Latin America Pemetrexed Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Pemetrexed Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pemetrexed Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pemetrexed Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pemetrexed Drug Sales by Type (2019-2030)
4.1.1 Global Pemetrexed Drug Sales by Type (2019-2024)
4.1.2 Global Pemetrexed Drug Sales by Type (2025-2030)
4.1.3 Global Pemetrexed Drug Sales Market Share by Type (2019-2030)
4.2 Global Pemetrexed Drug Revenue by Type (2019-2030)
4.2.1 Global Pemetrexed Drug Revenue by Type (2019-2024)
4.2.2 Global Pemetrexed Drug Revenue by Type (2025-2030)
4.2.3 Global Pemetrexed Drug Revenue Market Share by Type (2019-2030)
4.3 Global Pemetrexed Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pemetrexed Drug Sales by Application (2019-2030)
5.1.1 Global Pemetrexed Drug Sales by Application (2019-2024)
5.1.2 Global Pemetrexed Drug Sales by Application (2025-2030)
5.1.3 Global Pemetrexed Drug Sales Market Share by Application (2019-2030)
5.2 Global Pemetrexed Drug Revenue by Application (2019-2030)
5.2.1 Global Pemetrexed Drug Revenue by Application (2019-2024)
5.2.2 Global Pemetrexed Drug Revenue by Application (2025-2030)
5.2.3 Global Pemetrexed Drug Revenue Market Share by Application (2019-2030)
5.3 Global Pemetrexed Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Pemetrexed Drug Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Pemetrexed Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pemetrexed Drug Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Eagle Pharmaceuticals
6.4.1 Eagle Pharmaceuticals Corporation Information
6.4.2 Eagle Pharmaceuticals Description and Business Overview
6.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eagle Pharmaceuticals Pemetrexed Drug Product Portfolio
6.4.5 Eagle Pharmaceuticals Recent Developments/Updates
6.5 APOTEX
6.5.1 APOTEX Corporation Information
6.5.2 APOTEX Description and Business Overview
6.5.3 APOTEX Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 APOTEX Pemetrexed Drug Product Portfolio
6.5.5 APOTEX Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Corporation Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qilu Pharmaceutical Pemetrexed Drug Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pemetrexed Drug Industry Chain Analysis
7.2 Pemetrexed Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pemetrexed Drug Production Mode & Process
7.4 Pemetrexed Drug Sales and Marketing
7.4.1 Pemetrexed Drug Sales Channels
7.4.2 Pemetrexed Drug Distributors
7.5 Pemetrexed Drug Customers
8 Pemetrexed Drug Market Dynamics
8.1 Pemetrexed Drug Industry Trends
8.2 Pemetrexed Drug Market Drivers
8.3 Pemetrexed Drug Market Challenges
8.4 Pemetrexed Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pemetrexed Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pemetrexed Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pemetrexed Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pemetrexed Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pemetrexed Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pemetrexed Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pemetrexed Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pemetrexed Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pemetrexed Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pemetrexed Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pemetrexed Drug, Product Type & Application
Table 12. Global Key Manufacturers of Pemetrexed Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pemetrexed Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pemetrexed Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pemetrexed Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Pemetrexed Drug Sales Market Share by Region (2019-2024)
Table 19. Global Pemetrexed Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Pemetrexed Drug Sales Market Share by Region (2025-2030)
Table 21. Global Pemetrexed Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pemetrexed Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Pemetrexed Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pemetrexed Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pemetrexed Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Pemetrexed Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pemetrexed Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pemetrexed Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pemetrexed Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pemetrexed Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pemetrexed Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pemetrexed Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pemetrexed Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pemetrexed Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pemetrexed Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pemetrexed Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pemetrexed Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pemetrexed Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Pemetrexed Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Pemetrexed Drug Sales Market Share by Type (2019-2024)
Table 53. Global Pemetrexed Drug Sales Market Share by Type (2025-2030)
Table 54. Global Pemetrexed Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pemetrexed Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pemetrexed Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Pemetrexed Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Pemetrexed Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Pemetrexed Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Pemetrexed Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Pemetrexed Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Pemetrexed Drug Sales Market Share by Application (2019-2024)
Table 63. Global Pemetrexed Drug Sales Market Share by Application (2025-2030)
Table 64. Global Pemetrexed Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pemetrexed Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pemetrexed Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Pemetrexed Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Pemetrexed Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Pemetrexed Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Eli Lilly and Company Corporation Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Eli Lilly and Company Pemetrexed Drug Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Pemetrexed Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pemetrexed Drug Product
Table 84. Teva Recent Developments/Updates
Table 85. Eagle Pharmaceuticals Corporation Information
Table 86. Eagle Pharmaceuticals Description and Business Overview
Table 87. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eagle Pharmaceuticals Pemetrexed Drug Product
Table 89. Eagle Pharmaceuticals Recent Developments/Updates
Table 90. APOTEX Corporation Information
Table 91. APOTEX Description and Business Overview
Table 92. APOTEX Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. APOTEX Pemetrexed Drug Product
Table 94. APOTEX Recent Developments/Updates
Table 95. Qilu Pharmaceutical Corporation Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Qilu Pharmaceutical Pemetrexed Drug Product
Table 99. Qilu Pharmaceutical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Pemetrexed Drug Distributors List
Table 103. Pemetrexed Drug Customers List
Table 104. Pemetrexed Drug Market Trends
Table 105. Pemetrexed Drug Market Drivers
Table 106. Pemetrexed Drug Market Challenges
Table 107. Pemetrexed Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pemetrexed Drug
Figure 2. Global Pemetrexed Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pemetrexed Drug Market Share by Type in 2023 & 2030
Figure 4. 100 mg lyophilized powder/vial Product Picture
Figure 5. 500 mg lyophilized powder/vial Product Picture
Figure 6. Global Pemetrexed Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pemetrexed Drug Market Share by Application in 2023 & 2030
Figure 8. Pleural mesothelioma
Figure 9. Non-small cell lung cancer
Figure 10. Global Pemetrexed Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pemetrexed Drug Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pemetrexed Drug Sales (2019-2030) & (K Units)
Figure 13. Global Pemetrexed Drug Average Price (USD/Unit) & (2019-2030)
Figure 14. Pemetrexed Drug Report Years Considered
Figure 15. Pemetrexed Drug Sales Share by Manufacturers in 2023
Figure 16. Global Pemetrexed Drug Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pemetrexed Drug Players: Market Share by Revenue in 2023
Figure 18. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pemetrexed Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pemetrexed Drug Sales Market Share by Country (2019-2030)
Figure 21. North America Pemetrexed Drug Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pemetrexed Drug Sales Market Share by Country (2019-2030)
Figure 25. Europe Pemetrexed Drug Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pemetrexed Drug Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pemetrexed Drug Revenue Market Share by Region (2019-2030)
Figure 33. China Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pemetrexed Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Pemetrexed Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pemetrexed Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Pemetrexed Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pemetrexed Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pemetrexed Drug by Type (2019-2030)
Figure 55. Global Pemetrexed Drug Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pemetrexed Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pemetrexed Drug by Application (2019-2030)
Figure 58. Global Pemetrexed Drug Price (USD/Unit) by Application (2019-2030)
Figure 59. Pemetrexed Drug Value Chain
Figure 60. Pemetrexed Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
